IDEAYA Biosciences | Sustainability & Chart

US45166A1025

Basic information on IDEAYA Biosciences

Location: United States

Industry: Health Services

Website

Impact Score

Description IDEAYA Biosciences

IDEAYA Biosciences Inc. is a precision medicine oncology company focused on developing targeted therapeutics for the treatment of cancer.

IDEAYA Biosciences Sustainability Performance

Climate

Renewable Energy

No data available for IDEAYA Biosciences. Target value per method: min. 100%

Greenhouse Gas Emissions

No data available for IDEAYA Biosciences. Target value per method: max. 100% of CO₂ budget

Supply Chain

No data available for IDEAYA Biosciences. Target value per method: max. 100% of CO₂ budget

Recycling and Recovery of Waste

No data available for IDEAYA Biosciences. Target value per method: min. 75%

Society

50%

Union Formation and Collective Bargaining Power

IDEAYA Biosciences issues 0% collective agreements. Target value per method: min. 80%

CEO Pay Ratio

CEO Yujiro Hata earns 28 times the median salary of employees. Target value per method: max. 30 times

Employee Turnover Rate

No data available for IDEAYA Biosciences. Target value per method: max. 10%

Harassment and Discrimination at the Workplace

IDEAYA Biosciences meets 4 quality criteria for handling harassment and discrimination at the workplace. Target value per method: 4 quality criteria

Gender

53%

Women on Board

IDEAYA Biosciences has 42,9% women across its top leadership and supervisory bodies. Target value per method: min. 40%

Gender Pay Gap

No data available for IDEAYA Biosciences. Target value per method: max. 3%

Women in Management

IDEAYA Biosciences employs 23% female managers. Target value per method: min. 40%

Glass Ceiling

The proportion of women in senior management at IDEAYA Biosciences is 47,9% of the proportion of women in the overall workforce. Target value per method: min. 90%

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

Renewable Energy

Greenhouse Gas Emissions

Supply Chain

Waste Recycling

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare IDEAYA Biosciences with ...

IDEAYA Biosciences

?

Impact Score

Climate

Society

Gender

50%

53%

IDEAYA Biosciences

?

Impact Score

Climate

Society

Gender

Sources of sustainability performance

Metric	Value	Unit	Year	PDF Name	PDF Page
CEO Pay Ratio
CEO name	Yujiro Hata		2025	IDYA (IDEAYA Biosciences Inc.) (10-K) 2026-02-17.pdf_.pdf	151
CEO-to-median-salary-ratio	28	ratio	2025	IDYA (IDEAYA Biosciences Inc.) (DEF 14A) 2026-04-29.pdf_.pdf	43
Glass Ceiling
Women in workforce	48	%	2025	IDYA (IDEAYA Biosciences Inc.) (10-K) 2026-02-17.pdf_.pdf	39
Women in management	23	%	2025	IDYA (IDEAYA Biosciences Inc.) (10-K) 2026-02-17.pdf_.pdf	39
Harassment and Discrimination at the Workplace
Confidentiality mechanisms	Yes		2025	IDEAYA - [APPROVED] Tab 11 - Code of Business Conduct and Ethics_12.16.21.pdf	1
Retaliation safeguards	Yes		2025	IDEAYA - [APPROVED] Tab 11 - Code of Business Conduct and Ethics_12.16.21.pdf	2
Incident notification mechanism	Yes		2025	IDEAYA - [APPROVED] Tab 11 - Code of Business Conduct and Ethics_12.16.21.pdf	1
Anti-discrimination policy	Yes		2025	IDEAYA - [APPROVED] Tab 11 - Code of Business Conduct and Ethics_12.16.21.pdf	6
Union Formation and Collective Bargaining Power
Collective bargaining agreements coverage	0	%	2025	IDYA (IDEAYA Biosciences Inc.) (10-K) 2026-02-17.pdf_.pdf	39
Women on Board
Women on supervisory board	3	people	2025	IDYA (IDEAYA Biosciences Inc.) (DEF 14A) 2026-04-29.pdf_.pdf	26
Supervisory board size	7	people	2025	IDYA (IDEAYA Biosciences Inc.) (DEF 14A) 2026-04-29.pdf_.pdf	26
Women in Management
Women in management	23	%	2025	IDYA (IDEAYA Biosciences Inc.) (10-K) 2026-02-17.pdf_.pdf	39

Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

Home Find Companies & ETFs Learn to invest Academy Glossary Our Method

Imprint Privacy Policy GTCContact UsESG Rating Disclosure

© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support! Reference data includes information from ESMA FIRDS that has been transformed and enriched by money:care. The use of this reference data does not constitute endorsement of or support for money:care or its products by ESMA. Fund information is based in part on publications by the respective providers and has been processed by money:care. Logos provided by Logo.dev